Nonpharmacologic Treatment of Functional Abdominal Pain Disorders: A Systematic Review. Pediatrics


BACKGROUND AND

OBJECTIVE: Various nonpharmacologic treatments are available for pediatric abdominal pain-related functional gastrointestinal disorders (APFGIDs). Data on efficacy and safety are scarce. The goal of this study was to summarize the evidence regarding nonpharmacologic interventions for pediatric AP-FGIDs: lifestyle interventions, dietary interventions, behavioral interventions, prebiotics and probiotics, and alternative medicine.
METHODS: Searches were conducted of the Medline and Cochrane Library databases. Systematic reviews and randomized controlled trials (RCTs) concerning nonpharmacologic therapies in children (aged 3-18 years) with AP-FGIDs were included, and data were extracted on participants, interventions, and outcomes. The quality of evidence was assessed by using the GRADE approach.
RESULTS: Twenty-four RCTs were found that included 1390 children. Significant improvement of abdominal pain was reported after hypnotherapy compared with standard care/wait-list approaches and after cognitive behavioral therapy compared with a variety of control treatments/wait-list approaches. Written self-disclosure improved pain frequency at the 6-month follow-up only. Compared with placebo, Lactobacillus rhamnosus GG (LGG) and VSL#3 were associated with significantly more treatment responders (LGG relative risk: 1.31 [95% confidence interval: 1.08 to 1.59]; VSL#3: P < .05). Guar gum significantly improved irritable bowel syndrome symptom frequency; however, no effect was found for other fiber supplements (relative risk: 1.17 [95% confidence interval: 0.75 to 1.81]) or a lactose-free diet. Functional disability was not significantly decreased after yoga compared with a wait-list approach. No studies were found concerning lifestyle interventions; gluten-, histamine-, or carbonic acid-free diets; fluid intake; or prebiotics. No serious adverse effects were reported. The quality of evidence was found to be very low to moderate.
CONCLUSIONS: Although high-quality studies are lacking, some evidence shows efficacy of hypnotherapy, cognitive behavioral therapy, and probiotics (LGG and VSL#3) in pediatric AP-FGIDs. Data on fiber supplements are inconclusive.

Rutten JM, Korterink JJ, Venmans LM, et al. Nonpharmacologic Treatment of Functional Abdominal Pain Disorders: A Systematic Review. Pediatrics. 2015 Mar;135(3):522-535. Epub 2015 Feb 9. (Review) PMID: 25667239

Antigeno Prostatico Especifico: inutil para el cribado de cancer de prostata


Todavia desconozco en que idioma hay que escribir esto, pero por enesima  vez sale otro articulo que dice que la PSA,  no tiene ninguna utilidad en el cribado de cáncer de próstata y que sólo sirve para el seguimiento de pacientes con Cáncer de prostata. El tema es simple. Se trata de una prueba inespecifica, y el famoso antigeno es volumen-dependiente del tamaño de la prostata. Por ende, en la natural evolucion que tenemos los hombres la prostata se agranda con la edad. Por tanto, ningun valor sirve para diferenciar si ese agrandamiento se  debió a la hipertrofia prostática benigna, que también es muy común luego de los 65 años. Por otro lado, un viejo anatomista,  Testut, ya escribia en su tratado que data del año 1900, que en sus autopsias encontraba un 100% de cáncer de prostata en hombres  mayores de 80 años. En otras palabras, y aunque los urólogos se empeñen en poner al cancer de próstata como un grave problema de salud, colocandolo entre las primeras causas de muerte, la realidad indica, que nos morimos más con cáncer de próstata que por el cáncer mismo. Por ende es un buen marcador de la evolución del cáncer pero no tiene ninguna utilidad, escrito en Inglés (también ha sido escrito en castellano, catalán, portugues, francés, ruso, y seguramente en esperanto) por el  British Medical Journal.
Por ende tendremos que seguir lidiando con los expertos que aparecen en la prensa de todo el mundo, e intentan convencer a la gente de hacerse estos estudios desde los 50 años.

Utilizando una cohorte grande Seuca relacionada con un registro nacional de cáncer, los investigadores compararon los valores iniciales de PSA de aquellos que desarrollaron cáncer de próstata en el curso de 7 años post escrutinio, con otros hombres de similares características que no desarrollaron cáncer de próstata. La sobreposición de los valores de PSA frustraron los esfuerzos de los investigadores de encontrar un valor que tenga alta especificidad así como una sensibilidad del 50%. Sin embargo, notaron que un valor de PSA menor de 1 ng/mL virtualmente descarta el diagnóstico durante el período de seguimiento.

Debido a los resultados de este estudio, se podría decir que los datos sobre los costos y beneficios de las pruebas de PSA permanecen insuficientes para apoyar el escrutinio masivo.

Referencia: Benny Holmström, et al. Prostate specific antigen for early detection of prostate cancer: longitudinal study. BMJ. Septiembre 2009;339:b3537.

Reading Journals and monitoring the published work


No se esfuercen, ni critiquen, no tenia la menor idea de como llamar a este topico. Alguna vez lo llame “Gerenciamiento de la Informacion”, pero deja varios temas afuera, “Como leer articulos medicos” ya es el titulo de uno de los articulos que voy a presentar en algun momento, asi que, a sabienndas que la bibliometria tiene muchos mas recursos que los que yo puedo aportar aqui, tampoco quise poner ese nombre. Si hay millones de articulos medicos, la cantidad de articulos cientificos que nos dicen como leer los mismos y no morir en el intento, no resulta menor. A tal punto que ya hay varios blogs que se dedican a esto. En mi caso, empezo con la busqueda de un original de un articulo del cual habia leido el resumen y me intereso. Con todas mis nuevas herramientas de ubuntu, y agregando otras que ya provee mozilla, puedo asegurarles que aun asi, intentar mostrar el articulo no fue facil. Asi que pueden leer dos articulos: una que encontre en la revista Atencion Primaria: “Como estar actualizado a traves de Internet” (que lo guarde porque es toda una obra de museo, y que nos recuerda que hace 12 años, era posible leer el BMJ en forma gratuita, al menos en España, y la version original del que buscaba: Wyatt. Reading journals J R Soc Med 2000 93 423-7.
El primero no esta indexado en Medline, lo que suele aparejar ciertas dificultades con muchas revistas en nuestro idioma. Aunque en el original figure una version en Ingles, seguramente agregada luego que Elselvier se hiciera cargo. Por cierto, existe la posibilidad que podamos suscribirnos y leer el texto en forma gratuita, supongo que luego de 5 años de publicado.
Claro que parte de esta serie que inicio, tiene como objetivo tambien que los articulos sean citados correctamente. Algo que tampoco resulta facil, ya que existen distintos programas que nos permiten “administrar” nuestra bibliografia. Y en este caso, elegi hacerlo bajo las normas de Vancouver, utilizando un interesante recurso que se llama ……Citeulike
No lo voy a poder hacer en el primer caso (por cuestiones de tiempo nada mas). Pero si intentare hacerlo en forma automatizada a traves de Citeulike……………..luego de 15 minutos me rindo, no lo logre :-(

BMJ: How to read a paper


Education and debate

Papers that go beyond numbers (qualitative research)

Trisha Greenhalgh, Rod Taylor Papers that summarise other papers (systematic reviews and meta-analyses)

Trisha Greenhalgh

Papers that tell you what things cost (economic analyses)

Trisha Greenhalgh

Papers that report diagnostic or screening tests

Trisha Greenhalgh

Papers that report drug trials

Trisha Greenhalgh

Statistics for the non-statistician. II: “Significant” relations and their pitfalls

Trisha Greenhalgh

Statistics for the non-statistician

Trisha Greenhalgh

Assessing the methodological quality of published papers

Trisha Greenhalgh

Getting your bearings (deciding what the paper is about)

Trisha Greenhalgh

The Medline database

Trisha Greenhalgh

If you would like to order a copy of this book, please visit the BMJ Publishing Group website (under Medical Journalism/Research)

English: Histogram of sepal widths for Iris ve...
English: Histogram of sepal widths for Iris versicolor from Fisher’s Iris flower data set. SVG redraw of original image. (Photo credit: Wikipedia)

Oseltamivir ( Tamiflu ) : Más daños que beneficios.


BMJ
BMJ (Photo credit: Wikipedia)

Esto se desprende un artículo del BMJ, luego de mucho tiempo de espera de que el fabricante expusiera finalmente los articulos no publicados.
Los beneficios se reducen a una reducción de 1,5 a 0,5 dias aproximadamente de disminución de los síntomas. Sin beneficios en asmáticos, y sin poder prevenir otras infecciones que suelen asociarse en la Influenza.
Los efectos adversos, algunos de ellos frecuentes, parecen anular esta ecuación de Riesgo-Beneficio-Intervención-Costo. En particular los efectos psiquiatricos en niños, no frecuentes  pero relevantes.
Si bien este informe es nuevo, las explicaciones de la OMS o el CDC, de su elección como medicamento esencial permanecen oscuras.
Hasta el año pasado Colaboración Cochrane se habia negado a evaluar el medicamento si no se disponia de toda la información que el laboratorio tenía en su poder. Finalmente esta información fue entregada. Basta saber ahora, cual será la actitud de los gobiernos ante las compras masivas del medicamento en todo el mundo. Y seria interesante conocer la opinión de la OMS ante evidencias irrefutables, ya que este metanalisis fue realizado con estudios provenientes del propio fabricante. –  Para ver el artículo del BMJ aqui.

 

 

Influencia de las migraciones en Reino Unido sobre conducta materna


Influence of moving to the UK on maternal health behaviours: prospective cohort study

Summer Sherburne Hawkins, research fellow, Kate Lamb, MSc student, Tim J Cole, professor, Catherine Law, professor, the Millennium Cohort Study Child Health Group

1 Centre for Paediatric Epidemiology and Biostatistics, UCL Institute of Child Health, London WC1N 1EH

Correspondence to: S S Hawkins s.hawkins@ich.ucl.ac.uk<!–
var u = “s.hawkins”, d = “ich.ucl.ac.uk”; document.getElementById(“em0″).innerHTML = ‘<a href=”mailto:’ + u + ‘@’ + d + ‘”>’ + u + ‘@’ + d + ‘<\/a>’//–>

Abstract

Objective To compare health behaviours during pregnancy (smoking and alcohol consumption) and after birth (initiation and duration of breast feeding) between British/Irish white mothers and mothers from ethnic minority groups; and, in mothers from ethnic minority groups, to examine whether indicators of acculturation (generational status, language spoken at home, length of residency in the United Kingdom) were associated with these health behaviours.

Design Prospective nationally representative cohort study.

Setting England.

Participants 6478 British/Irish white mothers and 2110 mothers from ethnic minority groups.

Main outcome measures Any smoking during pregnancy; any alcohol consumption during pregnancy; initiation of breast feeding; breast feeding for at least four months.

Results Compared with British/Irish white mothers, mothers from ethnic minority groups were less likely to smoke (15% v 37%) or consume alcohol (14% v 37%) during pregnancy but more likely to initiate breast feeding (86% v 69%) and breast feed for at least four months (40% v 27%). Among mothers from ethnic minority groups, first and second generation mothers were more likely to smoke during pregnancy (odds ratio 3.85, 95% confidence interval 2.50 to 5.93, and 4.70, 2.49 to 8.90, respectively), less likely to initiate breast feeding (0.92, 0.88 to 0.97, and 0.86, 0.75 to 0.99), and less likely to breast feed for at least four months (0.72, 0.62 to 0.83, and 0.52, 0.30 to 0.89) than immigrants, after adjustment for sociodemographic characteristics. There were no consistent differences in alcohol consumption. Among immigrants, for every additional five years spent in the UK the likelihood of mothers smoking during pregnancy increased by 31% (4% to 66%) and they were 5% (0% to 10%) less likely to breast feed for at least four months.

Conclusions After immigration, maternal health behaviours worsen with length of residency in the UK. Health professionals should not underestimate women’s likelihood of engaging in risky health behaviours because of their ethnicity.

Introduction

The adverse effects of smoking1 2 and alcohol consumption3 during pregnancy and the beneficial effects of breast feeding4 on maternal and child health are well known. Many women from resource-rich countries, however, do not adhere to recommendations,1 5 6 7 8 9 10 including those to reduce smoking11 12 and stop drinking13 during pregnancy and breast feed exclusively for six months.14 Research from the United States has shown that maternal health behaviours vary by country of birth and length of residency, two indicators of acculturation.15 16 17 18 19 20 21 22 23 24 Acculturation is the adoption of health behaviours from the new dominant culture and loss of health behaviours from the original culture.25 26 In the US, acculturation has been associated with an increase in smoking15 16 17 18 and alcohol consumption15 16 17 during pregnancy as well as a reduction in initiation19 20 21 22 23 24 and duration19 23 24 of breast feeding.

Over the past 50 years immigration into the United Kingdom has increased, primarily from South Asia, the Caribbean, Europe, and Africa.27 In 2001-2, 7.6% of the population was from an ethnic minority group, an increase of 44% over the previous decade.28 Women from ethnic minority groups are less likely to smoke or consume alcohol than the general population in England29 and more likely to initiate and continue breast feeding than white mothers.7

We compared health behaviours during pregnancy (smoking and alcohol consumption) and after birth (initiation and duration of breast feeding) between British/Irish white mothers and mothers from ethnic minority groups in a nationally representative, contemporary cohort of mothers in England. We also examined how indicators of acculturation (measured by generational status, language spoken at home, length of residency in the UK) were associated with these health behaviours.

Methods

Participants
The millennium cohort study is a prospective study of children born in the UK in the new century. We used a stratified clustered sampling framework to over-represent children from ethnic minority groups and disadvantaged areas. In England, electoral wards (as established in 1998) were categorised as “ethnic” (based on the 1991 census, if at least 30% of residents were from an ethnic minority group) and the remainder as “disadvantaged” (the upper quarter of the child poverty index) or “advantaged” (all remaining wards). In Wales, Scotland, and Northern Ireland there was no “ethnic” stratum.30 Families were invited to participate if they were eligible for child benefit and resident in the UK when their child was aged 9 months. The original cohort comprised 18 819 children (18 553 families) born between September 2000 and January 2002 (72% response).30 About 80% (14 630) participated in the second contact, in September 2003 to January 2005, when the children were aged 3 years.31 At both contacts, information was collected through interviews of main respondents in the home. Translators were available.32

We focused on families in England because numbers were insufficient to analyse by ethnic group in Wales, Scotland, or Northern Ireland. Among the 11 695 mothers with singleton children at the first contact, 79% (9184) participated in the second. Families from “ethnic” and “disadvantaged” electoral wards were less likely to participate in the second contact,31 but non-response weights are available and were used to allow for differential attrition. Data were accessed through the UK Data Archive, University of Essex.

Among the 9184 mothers with singleton children in England at both contacts, we included 8588 in the analyses. We excluded families if information was missing on the main respondent’s ethnicity (46), the main respondent was not female (139) or a natural mother (53), there were two cohort children from the same family (8), or the main respondent had missing information on her generational status (370), language spoken at home (0), length of residency in the UK (193), initiation of breast feeding (15), duration of breast feeding (15), smoking during pregnancy (41), or alcohol consumption during pregnancy (16). Some families satisfied more than one exclusion criterion.

At the first contact, mothers reported their own ethnicity (out of 16 possible choices), which was classified according to guidelines from the Office for National Statistics.33 White women were categorised as either from any UK country or the Republic of Ireland (referred to as “British/Irish”) or from any other country (referred to as “other white”).5 To increase sample size we collapsed ethnic groups into British/Irish white, Pakistani or Bangladeshi, black (black African, black Caribbean, other black), Indian, other white (such as white European, North American), other (such as Sri Lankan, Arab), or mixed.

Sociodemographic characteristics were based on maternal self report at the first contact. Maternal socioeconomic circumstances were categorised according to the National Statistics socioeconomic classification,34 maternal education was defined as the highest academic qualification attained, and single motherhood status was defined as being a single mother when the child was aged 9 months. Mothers also reported whether the cohort child was their first live birth (parity), and their age at the birth of the cohort child. We included family income at the first contact; if it was missing we substituted values from the second contact (483).

Outcome measures
Smoking and alcohol consumption during pregnancy—At the first contact, mothers were asked about their smoking and drinking habits during pregnancy. Mothers reported their smoking habits before pregnancy and were asked whether they changed during pregnancy. Mothers were classified as having smoked if they reported smoking any number of cigarettes during pregnancy. Mothers also reported how often they drank alcoholduring pregnancy, ranging from never to every day. Mothers were classified as having consumed alcohol if they reported consuming any amount of alcohol during pregnancy. At the time when the mothers were pregnant, government recommendations were that pregnant women should drink no more than one or two units of alcohol once or twice a week and avoid intoxication.35

Initiation and duration of breast feeding—At the first contact, mothers were asked about their infant feeding practices. Initiation of breast feeding was defined as the baby having received any breast milk. Duration was categorised as being either fully or partially breast fed for at least four calendar months (≥17.4 weeks) or less than four months.5 At the time of the cohort births, the World Health Organization recommended that babies were breast fed for at least four months.36

Indicators of acculturation
Generational status—At the second contact, main respondents reported whether they, their mother, and their father were born in the UK or Republic of Ireland and, if not, their country of birth. Mothers were classified as immigrants (neither they nor either parent were born in the UK or Republic of Ireland), first generation (they were born in the UK or Republic of Ireland, but at least one parent was born outside the UK or Republic of Ireland), or second generation (both they and their parents were born in the UK or Republic of Ireland).

Language spoken at home—At the first contact, main respondents reported whether the language usually spoken at home was English, English and another language, or another language only.

Length of residency in the UK—At the second contact, main respondents who were not born in the UK or Republic of Ireland were asked the year when they arrived in the UK. This was subtracted from the year of the interview at the first contact to give the length of residency.

Statistical analyses
All analyses were conducted with STATA statistical software, version 9.2 SE (Stata Corporation, TX), with survey commands to account for the clustered sampling framework and obtain robust standard errors. We derived weighted percentages and conducted analyses using survey and non-response weights to allow for the clustered sampling and attrition between contacts. Proportions were compared with Pearson’s {chi}2 tests with the Rao and Scott second order correction.37 We included British/Irish white mothers to provide baseline characteristics of the majority ethnic group in England. Health behaviours during pregnancy (smoking and alcohol consumption) and after birth (initiation and duration of breast feeding) were compared by maternal ethnic group. Continue reading Influencia de las migraciones en Reino Unido sobre conducta materna

Sesgos en metanalisis*


Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study

Publicdo y actualizado en http://medicinafamiliar.info el 12/01/2010.

British Medical Journal. Vol. 336. Núm. 7644


British Medical Journal. Vol. 336. Núm. 7644

Originales

Ellis JM, Tan HK, Gilbert RE, Muller DPR, Henley W, Moy R et al. Supplementation with antioxidants and folinic acid for children with Down’s syndrome: randomised controlled trial. Págs. 594-597 R TC PDF

Parkes G, Greenhalgh T, Griffin M, Dent R. Effect on smoking quit rate of telling patients their lung age: the Step2quit randomised controlled trial. Págs. 598-600 R TC PDF

Editoriales

Bize R, Cornuz J. Incentives to quit smoking in primary care. Págs. 567-568 TC (s) PDF (s)

Reynolds T. Giving antioxidants to infants with Down’s syndrome. Págs. 568-569 TC (s) PDF (s)

Ali A, Hassiotis A. Illness in people with intellectual disabilities. Págs. 570-571 TC (s) PDF (s)

Melzer D, Hogarth S, Liddell K, Ling T, Sanderson S, Zimmern RL. Genetic tests for common diseases: new insights, old concerns. Págs. 590-593 TC (s) PDF (s)

Revisiones

Milton JC, Hill-Smith I, Jackson SHD. Prescribing for older people. Págs. 606-609 TC (s) PDF (s)

Comentario

Wilt TJ. Controversies in NICE guidance on prostate cancer. Págs. 612-614 TC (s) PDF (s)

Práctica clínica

Lip GYH. Don’t add aspirin for associated stable vascular disease in a patient with atrial fibrillation receiving anticoagulation. Págs. 614-615 TC (s) PDF (s)

Guías de práctica clínica

Graham J, Baker M, Macbeth F, Titshall V on behalf of the Guideline Development Group. Diagnosis and treatment of prostate cancer: summary of NICE guidance. Págs. 610-612 TC (s) PDF (s)

UK experts call for national system to evaluate diagnostic tests


UK experts call for national system to evaluate diagnostic tests

Susan Mayor

1 London

the first 150 words of the full text of this article appear below.

A national system should be introduced to evaluate diagnostic tests for use by the NHS, a report published this week recommends. It warns that currently no process is available for deciding which of the rapidly growing number of new tests should be used.

Such an evaluation system should extend to tests and scans aimed at people who are well, making information available to the public to warn them that many of these tests are not useful and can be harmful, according to a second report.

The first report, The Evaluation of Diagnostic Laboratory Tests and Complex Biomarkers, notes that about one billion laboratory tests are performed each year in the United Kingdom. “NHS laboratories have sophisticated systems to ensure the analytical accuracy of the tests, yet no system is in place to ensure the clinical effectiveness and utility of individual tests,” warned Peter Furness, consultant histopathologist at the University . . . [Full text of this article]

Rapid Responses:

Read all Rapid Responses

Plain Films
Stephen LITTLEFAIR
bmj.com, 14 Mar 2008 [Full text]

La lactancia materna no es protectora contra asma y alergia


Para evaluar si la lactancia materna exclusiva y prolongada disminuye el riesgo de asma y alergia en la niñez hasta la edad de 6.5 años, investigadores en Montreal y Belarus llevaron a cabo un estudio anidado randomizado en 31 hospitales maternos de Belarus y sus policlínicas afiliadas, involucrando a 17046 parejas madre-hijo, siguiendo a 81.5% hasta la edad de 6.5 años.

Ellos encontraron: “La intervención experimental condujo a un gran incremento en lactancia materna exclusiva a 3 meses (44.3% vs 6.4%) y una prevalencia significativamente mayor de lactancia materna en todas las edades hasta e incluyendo los 12 meses. El grupo experimental no tuvo disminución en riesgos de síntomas y diagnósticos alérgicos o en pruebas cutáneas positivas. De hecho alérgicos, luego de la exclusión de tres lugares (3 experimentales y 3 controles) con tasa sospechosamente altas de pruebas cutáneas positivas, los riesgos aumentaron significativamente en el grupo experimental para cuatro de los cinco antígenos.”

Los investigadores concluyeron: “Estos resultados no apoyan un efecto protector de lactancia materna exclusiva y prolongada sobre asma o alergia.”

¿Quizás es el tipo de leche?

BMJ 2007;335:815 (20 Octubre), doi:10.1136/bmj.39304.464016.AE © 2007 BMJ Publishing Group.

Efecto de lactancia materna prolongada y exclusiva sobre el riesgo de alergia y asma: ensayo anidado randomizado. Michael S Kramer, Lidia Matush, Irina Vanilovich, Robert Platt, Natalia Bogdanovich, Zinaida Sevkovskaya, Irina Dzikovich, Gyorgy Shishko, Bruce Mazer, para Promotion of Breastfeeding Intervention Trial (PROBIT) Study Group. Correspondencia a: M S Kramer michael.kramer@mcgill.ca

Impact of functional status at six months on long term survival in patients with ischaemic stroke: prospective cohort studies


Texto Completo

Karsten Bruins Slot, clinical research fellow1, Eivind Berge, senior consultant1, Paul Dorman, consultant neurologist2, Steff Lewis, medical statistician3, Martin Dennis, professor3, Peter Sandercock, professor3, on behalf of the Oxfordshire Community Stroke Project, the International Stroke Trial (UK), and the Lothian Stroke Register

1 Department of Internal Medicine, Ullevaal University Hospital, NO-0407 Oslo, Norway, 2 Department of Neurology, Newcastle General Hospital, Newcastle upon Tyne, 3 Department of Clinical Neurosciences, Western General Hospital, Edinburgh

Correspondence to: K Bruins Slot karsten.bruins.slot@medisin.uio.no<!– var u = “karsten.bruins.slot”, d = “medisin.uio.no”; document.getElementById(“em0”).innerHTML = ‘‘ + u + ‘@’ + d + ”//–>

Objective To estimate the impact on long term survival of functional status at six months after ischaemic stroke. Design Prospective cohort study.

Settings Three cohorts: Oxfordshire community stroke project, Lothian stroke register, and the first international stroke trial (in the United Kingdom).

Participants 7710 patients with ischaemic stroke registered between 1981 and 2000 and followed up for a maximum of 19 years.

Main outcome measures Functional status at six months after stroke assessed with modified Rankin scale or “two simple questions.” Mortality during follow-up. Survival analysis with Kaplan-Meier curves, log rank test, and Cox’s regression model.

Results In a combined analysis of all three cohorts, among patients who survived to assessment six months after the index stroke, the subsequent median length of survival among those independent in daily living and those dependent was 9.7 years (95% confidence interval 8.9 to 10.6) and 6.0 years (5.7 to 6.4), respectively. In a combined analysis of the Oxfordshire and Lothian cohorts, subsequent median survival fell progressively from 12.9 years (10.0 to 15.9) for patients with a Rankin score of 0-1 at six months after the stroke to 2.5 years (1.4 to 3.5) for patients with a Rankin score of 5. All previously stated differences in median survival were significant (log rank test P<0.001). The influence of functional outcome on survival remained significant (P<0.05) in each cohort after adjustment for relevant covariates (such as age, presence of atrial fibrillation, visible infarct on computed tomography, subtype of stroke) in a Cox’s regression model.

Conclusion Functional status six months after an ischaemic stroke is associated with long term survival. Early interventions that reduce dependency at six months might have positive effects on long term survival.

Related Articles

Health, wealth, and politics
Trish Groves
BMJ 2008 336: 0. [Extract] [Full Text]
Functional status and long term outcome of stroke
Helen Rodgers and Richard Thomson
BMJ 2008 336: 337-338. [Extract] [Full Text]

This article has been cited by other articles:

Rodgers, H., Thomson, R. (2008). Functional status and long term outcome of stroke. BMJ 336: 337-338 [Full text]

How to read a paper: BMJ


HOW TO READ A PAPER

The basics of evidence based medicine
Second edition
TRISHA GREENHALGH
Department of Primary Care and Population Sciences
Royal Free and University College Medical School
London, UK
© BMJ Books 2001

Bajar texto completo

First published in 1997
Second impression 1997
Third impression 1998
Fourth impression 1998
Fifth impression 1999
Sixth impression 2000
Seventh impression 2000
Second Edition 2001
by the BMJ Publishing Group, BMA House,Tavistock Square, London WC1H 9JR
http://www.bmjbooks.com
British Library Cataloguing in Publication Data
A catalogue record for this book is available from the British Library
ISBN 0-7279-1578-9
Cover by Landmark Design, Croydon, Surrey
Typeset by FiSH Books, London
Printed and bound by MPG Books Ltd, Bodmin

Contents
Foreword to the first edition ix
Preface xiii
Preface to the first edition: Do you need
to read this book? xv
Acknowledgments xvii
1 Why read papers at all? 1
Does “evidence based medicine” simply mean
“reading medical papers”? 1
Why do people often groan when you mention evidence
based medicine? 3
Before you start: formulate the problem 8
2 Searching the literature 15
Reading medical articles 15
The Medline database 16
Problem 1:You are trying to find a particular paper
which you know exists 17
Problem 2:You want to answer a very specific
clinical question 22
Problem 3:You want to get general information quickly
about a well defined topic 25
Problem 4:Your search gives you lots of irrelevant
articles 29
Problem 5:Your search gives you no articles
at all or not as many as you expected 30 Continue reading How to read a paper: BMJ

British Medical Journal. Vol. 336. Núm. 7636


Originales

Gates S, Fisher JD, Cooke MW, Carter YH, Lamb SEMultifactorial assessment and targeted intervention for preventing falls and injuries among older people in community and emergency care settings: systematic review and meta-analysis. Págs. 130-133 R TC PDF

Graff MJL, Adang EMM, Vernooij-Dassen MJM, Dekker J, Jönsson L, Thijssen M et alCommunity occupational therapy for older patients with dementia and their care givers: cost effectiveness study. Págs. 134-138 R TC PDF

Underwood M, Ashby D, Cross P, Hennessy E, Letley L, Martin J et al on behalf of the TOIB study teamAdvice to use topical or oral ibuprofen for chronic knee pain in older people: randomised controlled trial and patient preference study. Págs. 138-142 R TC PDF

Editoriales

Dieppe POsteoarthritis of the knee in primary care. Págs. 105-106 TC (s) PDF (s)

Dixon JM, Montgomery DFollow-up after breast cancer. Págs. 107-108 TC (s) PDF (s)

Revisiones

Wilt TJ, N’Dow JBenign prostatic hyperplasia. Part 1—Diagnosis. Págs. 146-149 TC (s) PDF (s)

Análisis

Järvinen TLN, Sievänen H, Khan KM, Heinonen A, Kannus PShifting the focus in fracture prevention from osteoporosis to falls. Págs. 124-126 TC PDF

Alonso-Coello P, López A, Guyatt G, Moynihan RDrugs for pre-osteoporosis: prevention or disease mongering?. Págs. 126-129 TC PDF

Práctica clínica

Wee B, Reynolds JH, Bleetman ARational Imaging: Imaging after trauma to the neck. Págs. 154-157 TC (s) PDF (s)

Exceso de fármacos para mujeres sanas


Cuando el médico receta un fármaco, es difícil negarse a tomarlo. La mayoría de las veces tendría que tener razón, por lo que la prescripción de un fármaco debería ir acompañada de una serie de mejoras en el estado de salud o de una disminución considerable de los riesgos de sufrir una patología.

Un análisis publicado hoy en la revista British Medical Journal alerta sobre la posibilidad de que esto no sea así en lo referido a los fármacos para la osteoporosis.

Los autores están coordinados por el médico de familia del Hospital de Sant Pau y miembro del grupo de salud de la mujer de la Sociedad Española de Medicina Familiar y Comunitaria (SEMFYC) Pablo Alonso-Coello.

Según explican, la publicación de reanálisis de ensayos clínicos con medicamentos para la osteoporosis (enfermedad que supone la debilidad de los huesos, que se diagnostica cuando existe una densidad ósea baja) puede llevar a recetar medicamentos a mujeres con osteopenia, una condición que implica riesgo de tener osteoporosis y una debilidad ósea muy común en las mujeres mayores (se calcula que afecta a más de la mitad de éstas), pero que no es una  enfermedad en sí misma.

Problemas en las consultas

Según explica Alonso-Coello, el problema reside en no explicar bien las cosas a los pacientes: “Un estudio puede concluir, con razón, que el riesgo de sufrir fracturas disminuye un 50% en las mujeres con osteopenia que se medican, pero la cosa cambia si a eso se añade que ese riesgo es sólo del 1%”.

El médico comenta que estos resultados, que son explicados sólo parcialmente, son los que llegan a la consulta de los especialistas en los materiales promocionales que les facilitan los visitadores médicos de la industria farmacéutica: “Los reanálisis se han difundido para aumentar la cuota de mercado, lo que supone una cierta manipulación”.

Desde su identificación, la osteoporosis ha sido una enfermedad controvertida, tal y como destacan los autores en el trabajo publicado hoy.  “Para algunos, menos comprometidos con la industria, la popularización de la osteoporosis representa el clásico ejemplo de promoción de enfermedades: un factor de riesgo transformado en una patología para vender pruebas y fármacos a mujeres relativamente sanas”, se puede leer en el análisis.

Para Alonso-Coello, la osteoporosis “es como el exceso de colesterol; al igual que éste no implica que se vaya a sufrir un infarto, la primera no garantiza que se vayan a romper los huesos”.

El médico puntualiza que la Organización Mundial de la Salud está desarrollando un algoritmo de riesgo de fracturas que desvelará qué hacer con las mujeres con osteopenia ya que “cada vez está más claro que la densidad mineral ósea es un mal predictor del riesgo de fracturas”.

El polémico ‘disease mongering

El término en inglés es ‘disease mongering’ y se definiría como las prácticas de la industria farmacéutica para convertir fenómenos normales en enfermedades a través de la promoción de las dolencias inventadas, con la ayuda de los medios. Un especial de ‘PLoS Medicine’ recoge ejemplos concretos sobre esta práctica.

1. Disfunción eréctil

¿Quién había oído hablar de la disfunción eréctil antes de que un laboratorio desarrollara Viagra? Aunque el fármaco es sin duda eficaz para la disfunción eréctil  secundaria a enfermedades como la diabetes o la cirugía de la próstata, Pfizer no se quiso limitar a los hombres enfermos e hizo que se percibiera la disfunción eréctil como un problema para todos los mayores de 40 años.

2. Trastorno por defícit de atención con hiperactividad

¿Es el niño travieso o está enfermo y tiene que ser medicado? La industria farmacéutica se hizo presente en los colegios, coincidiendo con el desarrollo de fármacos para esta condición. Los maestros han jugado un papel destacado a la hora de alertar a los padres sobre este problema.

3. Síndrome de las piernas inquietas

El fabricante de un fármaco (aprobado previamente para el párkinson) fue acusado de promocionar en los medios una nueva enfermedad, el síndrome de las piernas inquietas, para obtener una nueva indicación para este medicamento.
Fuente: Publico.es

British Medical Journal: 08/12/2007 – Vol.335 Num.7631


[RESEARCH] New point of care Chlamydia Rapid Test bridging the gap between diagnosis and treatment: performance evaluation study

Objective To evaluate the performance of a new Chlamydia Rapid Test with vaginal swab specimens as a potential tool for chlamydia diagnosis and screening.

Design Performance evaluation study.

Settings A young people’s sexual health centre (site 1) and two genitourinary medicine clinics (sites 2 and 3) in the United Kingdom.

Participants 1349 women aged between 16 and 54 attending one of the three clinics.

Main outcome measures Sensitivity, specificity, positive predictive value, and negative predictive value of the Chlamydia Rapid Test versus polymerase chain reaction and strand displacement amplification assays; correlation between the Chlamydia Rapid Test visual signal and organism load; acceptability to participants of self collected vaginal swabs as the specimen type for Chlamydia testing.

Results Polymerase chain reaction positivity rates for Chlamydia trachomatis infection were 8.4% (56/663) at site 1, 9.4% (36/385) at site 2, and 6.0% (18/301) at site 3. Compared with polymerase chain reaction assay, the resolved sensitivity, specificity, positive predictive value, and negative predictive value of the Chlamydia Rapid Test were 83.5% (91/109), 98.9% (1224/1238), 86.7% (91/105), and 98.6% (1224/1242). Compared with strand displacement amplification assay, sensitivity and specificity of the Chlamydia Rapid Test were 81.6% (40/49) and 98.3% (578/588). Organism load of self collected vaginal swabs ranged from 5.97×102 to 1.09×109 Chlamydia plasmids per swab, which correlated well with the Chlamydia Rapid Test’s visual signal (r=0.6435, P<0.0001). Most (95.9%) surveyed participants felt comfortable about collecting their own swabs.

Conclusions The performance of the Chlamydia Rapid Test with self collected vaginal swabs indicates that it would be an effective same day diagnostic and screening tool for Chlamydia infection in women. The availability of Chlamydia Rapid Test results within 30 minutes allows for immediate treatment and contact tracing, potentially reducing the risks of persistent infection and onward transmission. It could also provide a simple and reliable alternative to nucleic acid amplification tests in chlamydia screening programmes.
[RESEARCH] Long term pharmacotherapy for obesity and overweight: updated meta-analysis

Objective To summarise the long term efficacy of anti-obesity drugs in reducing weight and improving health status.

Design Updated meta-analysis of randomised trials.

Data sources Medline, Embase, the Cochrane controlled trials register, the Current Science meta-register of controlled trials, and reference lists of identified articles. All data sources were searched from December 2002 (end date of last search) to December 2006.

Studies reviewed Double blind randomised placebo controlled trials of approved anti-obesity dugs used in adults (age over 18) for one year or longer.

Results 30 trials of one to four years’ duration met the inclusion criteria: 16 orlistat (n=10 631 participants), 10 sibutramine (n=2623), and four rimonabant (n=6365). Of these, 14 trials were new and 16 had previously been identified. Attrition rates averaged 30-40%. Compared with placebo, orlistat reduced weight by 2.9 kg (95% confidence interval 2.5 kg to 3.2 kg), sibutramine by 4.2 kg (3.6 kg to 4.7 kg), and rimonabant by 4.7 kg (4.1 kg to 5.3 kg). Patients receiving active drug treatment were significantly more likely to achieve 5% and 10% weight loss thresholds. Orlistat reduced the incidence of diabetes and improved concentrations of total cholesterol and low density lipoprotein cholesterol, blood pressure, and glycaemic control in patients with diabetes but increased rates of gastrointestinal side effects and slightly lowered concentrations of high density lipoprotein. Sibutramine lowered concentrations of high density lipoprotein cholesterol and triglycerides but raised blood pressure and pulse rate. Rimonabant improved concentrations of high density lipoprotein cholesterol and triglycerides, blood pressure, and glycaemic control in patients with diabetes but increased the risk of mood disorders.

Conclusions Orlistat, sibutramine, and rimonabant modestly reduce weight, have differing effects on cardiovascular risk profiles, and have specific adverse effects.
[RESEARCH] Mortality in men admitted to hospital with acute urinary retention: database analysis

Objectives To investigate mortality in men admitted to hospital with acute urinary retention and to report on the effects of comorbidity on mortality.

Design Analysis of the hospital episode statistics database linked to the mortality database of the Office for National Statistics.

Setting NHS hospital trusts in England, 1998-2005.

Participants All men aged over 45 who were admitted to NHS hospitals in England with a first episode of acute urinary retention.

Main outcome measures Mortality in the first year after acute urinary retention and standardised mortality ratio against the general population.

Results During the study period, 176 046 men aged over 45 were admitted to hospital with a first episode of acute urinary retention. In 100 067 men with spontaneous acute urinary retention, the one year mortality was 4.1% in men aged 45-54 and 32.8% in those aged 85 and over. In 75 979 men with precipitated acute urinary retention, mortality was 9.5% and 45.4%, respectively. In men with spontaneous acute urinary retention aged 75-84, the most prevalent age group, the one year mortality was 12.5% in men without comorbidity and 28.8% in men with comorbidity. The corresponding figures for men with precipitated acute urinary retention were 18.1% and 40.5%. Compared with the general population, the highest relative increase in mortality was in men aged 45-54 (standardised mortality ratio 10.0 for spontaneous and 23.6 for precipitated acute urinary retention) and the lowest for men 85 and over (1.7 and 2.4, respectively).

Conclusions Mortality in men admitted to hospital with acute urinary retention is high and increases strongly with age and comorbidity. Patients might benefit from multi-disciplinary care to identify and treat comorbid conditions. Continue reading British Medical Journal: 08/12/2007 – Vol.335 Num.7631

Radiaciones y gestion del riesgo


Hace unos dias leia en la prolifica lista MEDFAM un dato (que he usado en la presentación de la sesión sobre gestión del riesgo y que suscitó bastante controversia) sobre la cantidad de radiación recibida tras la realización de 5 TAC abdominales. Esa radiación es equivalente a la radiación media recibida tras la explosión de Hiroshima. Una radiación potencialmente peligrosa especialmente en personas jóvenes. Dejo en la parte inferior un articulo del BMJ donde se hace esta afirmación.
¿Cuantas personas hemos visto preocupadas por su salud y que realizan TACs a troche y moche en consultas privadas (y públicas) buscándose el cáncer que acabará con ellos? Tendríamos que comenzar a dar información sobre que quizás lo que les lleve a la tumba, si siguen por ese camino, es la propia técnica diagnóstica. A veces el peligro proviene de nuestro lado de la mesa.

La gestión de riesgo es un tema del que oiremos hablar cada vez más en nuestro entorno. La magnitud de las cifras nos impondrá un cambio de cultura, en este aspecto de la calidad.

Hoy he recibido un correo de Ernesto Barrera, (moderador de la lista antes mencionada) con un enlace a una pagina del Ministerio de Sanidad de un curso sobre “Seguridad del paciente y prevención de efectos adversos relacionados con la asistencia sanitaria”.
Lo he leído sin detenerme mucho, pero me parece muy bueno y sobre todo hay mucha información para profundizar en el tema (están activos muchos enlaces a bibliografía).

Documento en PDF

Fuente: tomado de Sinestesia Digital 

Comparative accuracy: assessing new tests against existing diagnostic pathways


Development and introduction of new diagnostic techniques have greatly accelerated over the past decades. The evaluation of diagnostic techniques, however, is less advanced than that of treatments. Unlike with drugs, there are generally no formal requirements for adoption of diagnostic tests in routine care. In spite of important contributions, 1 2 the methodology of diagnostic research is poorly defined compared with study designs on treatment effectiveness, or on aetiology, so it is not surprising that methodological flaws are common in diagnostic studies.3-5 Furthermore, research funds rarely cover diagnostic research starting from symptoms or tests.

Since quality of the diagnostic process largely determines quality of care, overcoming deficiencies in standards, methodology, and funding deserves high priority. This article summarises objectives of diagnostic testing and research, methodological challenges, and options for design of studies.

Texto Completo: http://www.bmj.com/cgi/reprint/324/7335/477.pdf Continue reading Comparative accuracy: assessing new tests against existing diagnostic pathways